Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05652374 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study

Study acronym: GT RACING
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 2025 to Oct 2027
    • Study sites: 1 to 3
    • Secondary endpoints: details revised at 7 of 7 entries
    • Study description expanded, about 36 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The GT RACING is a study comparing the efficacy of HA-CS bladder installations with prophylactic antibiotics in the prevention of recurrent urinary tract infections (rUTI).
Trial Details
NCT Number NCT05652374
Lead Sponsor Radboud University Medical Center
Collaborators: IBSA Institut Biochimique SA, Goodlife Pharma B.V.
Conditions
(from sponsor)		 Recurrent Urinary Tract Infection
Related terms Urinary Tract Infections
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov